Andrea Wang-Gillam Selected Research

ulixertinib

10/2018	Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models.
1/2018	First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Wang-Gillam Research Topics

Disease

52	Neoplasms (Cancer) 01/2022 - 07/2008
42	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 01/2010
40	Adenocarcinoma 11/2022 - 08/2011
4	Fatigue 01/2022 - 04/2015
4	Exanthema (Rash) 01/2022 - 06/2013
3	Lymphopenia (Lymphocytopenia) 01/2022 - 04/2015
3	Rectal Neoplasms (Rectal Cancer) 01/2021 - 03/2014
3	Diarrhea 01/2021 - 01/2019
3	Neutropenia 01/2021 - 01/2016
2	Thrombocytopenia (Thrombopenia) 12/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020 - 06/2017
2	Disease Progression 11/2016 - 12/2013
2	Febrile Neutropenia 01/2016 - 12/2014
2	Fever (Fevers) 04/2015 - 04/2004
2	Vitamin D Deficiency 09/2013 - 07/2008
1	Leukopenia 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Hemorrhage 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Nausea 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Stomatitis 01/2021
1	Ulcer 01/2021
1	Mucositis 01/2021

Drug/Important Bio-Agent (IBA)

19	Gemcitabine FDA Link 01/2020 - 06/2013
13	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 03/2014
11	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 02/2016
10	Leucovorin (Folinic Acid)FDA Link 01/2020 - 02/2016
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 01/2013
6	130-nm albumin-bound paclitaxelIBA 01/2021 - 12/2013
5	folfirinoxIBA 01/2020 - 09/2012
4	Proteins (Proteins, Gene)FDA Link 04/2017 - 06/2013
3	Docetaxel (Taxotere)FDA Link 01/2021 - 07/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2012
3	temsirolimus FDA Link 01/2021 - 08/2014
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2020 - 04/2015
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 06/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2019
2	vorolanibIBA 01/2022 - 10/2021
2	MTOR InhibitorsIBA 10/2021 - 01/2021
2	Aurora Kinase AIBA 01/2021 - 02/2016
2	Capecitabine (Xeloda)FDA Link 02/2020 - 06/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2013
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2017
2	MesothelinIBA 09/2019 - 04/2015
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2019 - 02/2017
2	ulixertinibIBA 10/2018 - 01/2018
2	AntigensIBA 03/2018 - 04/2015
2	VaccinesIBA 01/2018 - 04/2015
2	EnzymesIBA 04/2017 - 04/2015
2	AZD 6244IBA 04/2017 - 01/2013
2	taxaneIBA 07/2015 - 12/2014
2	Vitamin D FDA LinkGeneric 09/2013 - 07/2008
1	Methoxsalen (Oxsoralen)FDA Link 11/2022
1	Sirolimus (Rapamycin)FDA Link 11/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 11/2022
1	racemetyrosineIBA 11/2022
1	NivolumabIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	pembrolizumabIBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	cobimetinibIBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	atezolizumabIBA 12/2021
1	LigandsIBA 12/2021
1	Interleukin-15 (Interleukin 15)IBA 11/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Everolimus FDA Link 10/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	MLN 8237IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	AntralIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Taxoids (Taxanes)IBA 01/2021
1	IpilimumabIBA 10/2020
1	Cancer VaccinesIBA 10/2020
1	AminopeptidasesIBA 02/2020
1	tosedostatIBA 02/2020
1	durvalumabIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	LY2510924IBA 01/2020

Therapy/Procedure

24	Therapeutics 12/2021 - 07/2008
17	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
6	Radiotherapy 01/2021 - 12/2013
3	Neoadjuvant Therapy 01/2020 - 01/2012
3	Immunotherapy 03/2018 - 09/2014
2	Pancreaticoduodenectomy 05/2015 - 08/2011
1	Drug Tapering 01/2021
1	Injections 01/2021
1	Intravenous Injections 01/2021